Small-scale particles showing large-scale impact in pancreatic cancer

References

• 1. Sung H, Ferlay J, Siegel RL, Laversanne M et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209–249 (2021).
  MedlineGoogle Scholar
• 2. McGuigan A, Kelly P, Turkington RC et al. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment, and outcomes. World J. Gastroenterol. 24(43), 4846–4861 (2018).
  MedlineGoogle Scholar
• 3. National Institute for Health and Care Excellence. Pancreatic Cancer in Adults: Diagnosis and Management [NG85]. London, UK (2018).
  Google Scholar
• 4. Jouyandeh M, Sajadi SM, Seidi F et al. Metal nanoparticles-assisted early diagnosis of diseases. Open Nano 8, 100104 (2022).
  Google Scholar
• 5. Patra JK, Das G, Fraceto LF et al. Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnol. 16, 71 (2018).
  MedlineGoogle Scholar
• 6. Manzur A, Oluwasanmi A, Moss D et al. Nanotechnologies in pancreatic cancer therapy. Pharmaceutics 9(4), 39 (2017).
  MedlineGoogle Scholar
• 7. Urbanova M, Cihova M, Buocikova V et al. Nanomedicine and epigenetics: new alliances to increase the odds in pancreatic cancer survival. Biomed. Pharmacother. 165, 115179 (2023).
  Medline CASGoogle Scholar
• 8. Greene MK, Johnston MC, Scott CJ. Nanomedicine in pancreatic cancer: current status and future opportunities for overcoming therapy resistance. Cancers (Basel) 13(24), 6175 (2021).
  Medline CASGoogle Scholar
• 9. Hou W, Yang B, Zhu H. Nanoparticle-based therapeutic strategies for enhanced pancreatic ductal adenocarcinoma immunotherapy. Pharmaceutics 14(10), 2033 (2022).
  Medline CASGoogle Scholar
• 10. Kuncic Z, Lacombe S. Nanoparticle radio-enhancement: principles, progress and application to cancer treatment. Physics Med. Biol. 63, 2 (2018).
  Google Scholar
• 11. Guo Y, Zhang Z, Kim D et al. Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles. Int. J. Nanomed. 8(1), 3437–3446 (2013).
  MedlineGoogle Scholar
• 12. Raza F, Evans L, Motallebi M et al. Liposome-based diagnostic and therapeutic applications for pancreatic cancer. Acta Biomater. 157, 1–23 (2023).
  Medline CASGoogle Scholar
• 13. Nzeteu N, Aime G, Bernhard GF et al. Nanoparticle-based immunotherapy of pancreatic cancer. Front. Mol. Biosci. 9, 948898 (2022).
  Medline CASGoogle Scholar
• 14. Akanda M, Mithu MDSH, Douroumis D. Solid lipid nanoparticles: an effective lipid-based technology for cancer treatment. J. Drug Deliv. Sci. Technol. 86, 104709 (2023).
  CASGoogle Scholar
• 15. Ganesan P, Ramalingam P, Karthivashan G et al. Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases. Int. J. Nanomed. 13, 1569–1583 (2018).
  Medline CASGoogle Scholar
• 16. Caputo D, Pozzi D, Farolfi T et al. Nanotechnology and pancreatic cancer management: state of the art and further perspectives. World J. Gastrointest. Oncol. 13(4), 231–237 (2021).
  MedlineGoogle Scholar
• 17. Rehman U, Abourehab MAS, Alexander A et al. Polymeric micelles assisted combinatorial therapy: is it new hope for pancreatic cancer? Eur. Polym. J. 184, 111784 (2023).
  CASGoogle Scholar
• 18. Jaidev LR, Chede LS, Kandikattu HK. Theranostic nanoparticles for pancreatic cancer treatment. Endocr. Metab. Immune Disord. Drug Targets 21(2), 203–214 (2021).
  Medline CASGoogle Scholar